Camosunate (7-13 Years) – Pediatric Antimalarial Medication

Fast and Effective Malaria Treatment for Older Children

Camosunate (7-13 years) is a specialized antimalarial medication designed to treat uncomplicated malaria in children aged 7 to 13 years. This pediatric medication combines Artesunate and Amodiaquine, two powerful antimalarial agents that work together to rapidly clear Plasmodium falciparum parasites from your child's bloodstream, providing quick relief from malaria symptoms and preventing the disease from progressing. Camosunate is an essential treatment option for managing malaria in older children, ensuring both safety and efficacy in this age group.

Key Benefits

• Effective Malaria Treatment: Camosunate is specifically formulated to treat uncomplicated malaria caused by Plasmodium falciparum, the most dangerous malaria parasite, in children aged 7 to 13 years. It rapidly reduces the parasite load in the blood, providing quick relief from symptoms.
• Dual-Action Formula: The combination of Artesunate and Amodiaquine offers a synergistic effect, ensuring fast and effective parasite clearance. Artesunate kills the parasites in the blood, while Amodiaquine helps to prevent their reproduction and spread.
• Pediatric Formulation: Camosunate is designed with a dosage and formulation suitable for older children, making it easy to administer and ensuring that the medication is safe and effective for this age group.
• Prevents Drug Resistance: The dual-action formula helps to reduce the risk of drug resistance, a significant concern in malaria treatment. By using two active ingredients, Camosunate ensures a more effective and sustained treatment outcome.
• Easy Administration: The medication is formulated to be easy for children to take, helping parents and caregivers ensure that their child completes the full course of treatment for the best results.

Ingredients

• Active Ingredients:

  • Artesunate